NCT02196805 - A Bioequivalence Study Comparing a Single Oral Intake of an Imported PROBUCOL Tablet(Lorelco) With a Marketed PROBUCOL Tablet(Chang Tai) in Chinese Healthy Volunteers | Biotech Hunter

Enrollment

120

Participants

Timeline

Start Date

March 31, 2009

Primary Completion Date

September 30, 2009

Study Completion Date

December 31, 2009

Conditions

Chinese Healthy Volunteers

Interventions

DRUG

Group A: imported Probucol ( Lorelco)

Group A: take imported Probucol( Lorelco) (250mg/tablet), Qd, P.O.

DRUG

Group B: Marketed Probucol ( Chang Tai)

Group B: take Marketed Probucol(Chang Tai)(250mg/tablet), Qd, P.O.

Trial Locations (1)

Clinical Pharmacology Research Center Peking Union Medical College Hospital, Beijing